H. Vallerand

656 total citations
13 papers, 135 citations indexed

About

H. Vallerand is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, H. Vallerand has authored 13 papers receiving a total of 135 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in H. Vallerand's work include Tracheal and airway disorders (3 papers), Esophageal and GI Pathology (3 papers) and Vascular Anomalies and Treatments (2 papers). H. Vallerand is often cited by papers focused on Tracheal and airway disorders (3 papers), Esophageal and GI Pathology (3 papers) and Vascular Anomalies and Treatments (2 papers). H. Vallerand collaborates with scholars based in France. H. Vallerand's co-authors include A Toby Prevost, Gaëtan Deslée, F. Lavaud, François Lebargy, O Toubas, Gonzague Delépine, André Furco, F. Naudin, C. Hermant and Samy Lachkar and has published in prestigious journals such as Anesthesia & Analgesia, The Annals of Thoracic Surgery and Allergy.

In The Last Decade

H. Vallerand

13 papers receiving 126 citations

Peers

H. Vallerand

PRM

SURGE

PHYSI

ONCOL

ID

Anastasios Vagionas Greece

Aleš Rozman Slovenia

Naoko Fukuhara Japan

C. Godden United Kingdom

Miguel García González Spain

Enrique Cases Spain

Mary Noseworthy Canada

Ronald M. Angeles United States

Muhammad B. Hammami United States

Jonathan E. Spahr United States

Anastasios Vagionas Greece

H. Vallerand

74 ×1.2

PRM

21 ×0.6

SURGE

30 ×1.4

PHYSI

43 ×2.3

ONCOL

32 ×1.8

ID

Citations per year, relative to H. Vallerand H. Vallerand (= 1×) peers Anastasios Vagionas

Countries citing papers authored by H. Vallerand

Since Specialization

Citations

This map shows the geographic impact of H. Vallerand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Vallerand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Vallerand more than expected).

Fields of papers citing papers by H. Vallerand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Vallerand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Vallerand. The network helps show where H. Vallerand may publish in the future.

Co-authorship network of co-authors of H. Vallerand

This figure shows the co-authorship network connecting the top 25 collaborators of H. Vallerand. A scholar is included among the top collaborators of H. Vallerand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Vallerand. H. Vallerand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Perrier, Marine, Camille Mazza, Alain Delmer, et al.. (2022). Feasibility and Impact of Adapted Physical Activity (APA) in Cancer Outpatients Beginning Medical Anti-Tumoral Treatment: The UMA-CHAPA Study. Cancers. 14(8). 1993–1993. 3 indexed citations

2.

Dutau, Hervé, M. Febvre, L. Cellerin, et al.. (2020). Impact of Silicone Stent Placement in Symptomatic Airway Obstruction due to Non-Small Cell Lung Cancer – A French Multicenter Randomized Controlled Study: The SPOC Trial. Respiration. 99(4). 344–352. 27 indexed citations

3.

Boleto, Gonçalo, Jeanne‐Marie Perotin, Claire Launois, et al.. (2017). Nuclear protein in testis carcinoma of the mediastinum: a case report. Journal of Medical Case Reports. 11(1). 152–152. 4 indexed citations

4.

Launois, Claire, Jeanne‐Marie Perotin, Sandra Dury, et al.. (2017). Hypoventilation alvéolaire sévère révélant un shrinking lung syndrome lupique. Revue des Maladies Respiratoires. 34(5). 571–575. 1 indexed citations

5.

Launois, Claire, H. Vallerand, Sandra Dury, et al.. (2016). Obstructive Fibrinous Tracheal Pseudomembrane. Anesthesia & Analgesia. 125(1). 172–175. 4 indexed citations

6.

Papathanassiou, Dimitri, Olivier Bouché, A Toby Prevost, et al.. (2015). Incidental gastrointestinal 18F-Fluorodeoxyglucose uptake associated with lung cancer. BMC Pulmonary Medicine. 15(1). 152–152. 3 indexed citations

7.

Perotin, Jeanne‐Marie, H. Léna, Hervé Dutau, et al.. (2011). Endoscopic Management of Idiopathic Tracheal Stenosis. The Annals of Thoracic Surgery. 38(1). 297–301. 4 indexed citations

8.

Deslée, Gaëtan, et al.. (2005). Therapeutic Management of Broncholithiasis. The Annals of Thoracic Surgery. 79(5). 1774–1776. 26 indexed citations

9.

Furco, André, et al.. (2001). [Pulmonary mucormycosis: benefit of aerosol amphotericin B?].. PubMed. 18(3). 309–13. 12 indexed citations

10.

Léone, J., et al.. (1996). Manifestations pulmonaires du syndrome de Gougerot-Sjögren primitif. À propos de huit observations dans une série de 35 patients. La Revue de Médecine Interne. 17(4). 291–299. 7 indexed citations

11.

Lavaud, F., et al.. (1994). Baker's asthma related to soybean lecithin exposure. Allergy. 49(3). 159–162. 27 indexed citations

12.

Prevost, A Toby, et al.. (1994). [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE].. PubMed. 11(4). 379–84. 2 indexed citations

13.

Collery, Philippe, et al.. (1992). Combination chemotherapy with cisplatin, etoposide and gallium chloride for lung cancer: individual adaptation of doses.. PubMed. 11(4). 1529–32. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact